VitMode

Resveratrol

The red-grape polyphenol famed as a 'sirtuin activator' — but its bioavailability in humans is very low, which limits the practical relevance of many striking test-tube results.

AKdr Anna KowalczykReviewed by dr Piotr ZielińskiUpdated: 22 czerwca 2026
Early-stage evidence
3.9

Number of studies

2

Safety

Moderate

Time to effects

Clinical data are limited — small studies have described preliminary improvement in vascular endothelial function after a few to several weeks of supplementation.

Monthly cost

ok. 50–100 zł/miesiąc

Price in Poland

50–100 zł za 60 kapsułek trans-resweratrolu (miesiąc stosowania)

Who it's for

People interested in supporting vascular health as part of a broader longevity strategyPeople aware of the bioavailability limitations, willing to treat it as a supporting supplement rather than a key one

Formy mikronizowane/liposomalne o lepszej biodostępności bywają o 30–50% droższe.

Indicative prices for the Polish market — we don't point to specific retailers; the real price depends on the manufacturer, form and place of purchase.

Table of contents

TL;DR

The red-grape polyphenol famed as a 'sirtuin activator' — but its bioavailability in humans is very low, which limits the practical relevance of many striking test-tube results.

  • In animals: improved metabolic parameters and lifespan extension in some models (mainly on a high-fat diet)
  • In humans: preliminary data on a beneficial effect on vascular endothelial function
  • Preliminary data on anti-inflammatory and antioxidant properties in small clinical studies
Chemical groupPolyphenol (stilbene)
Main sourcesRed grape skin, red wine, Japanese knotweed
Supplement formTrans-resveratrol (the only biologically active form)
Typical dose150–500 mg/day (the effective human dose is not firmly established)
Evidence levelPreliminary — promising in-vitro data, modest clinical effects in humans
InteractionsYes — anticoagulants/antiplatelet drugs, CYP3A4 substrates
StatusDietary supplement, available without a prescription

Understand

Overview

Resveratrol is a stilbene-class polyphenol found in the skin of red grapes, red wine, peanuts and berries, where the plant produces it as a natural defense against fungi and UV radiation (a so-called phytoalexin). It owes its fame mainly to research from the mid-2000s that kicked off the 'French paradox' hypothesis — the observation that people in France have relatively low cardiovascular mortality despite a diet rich in saturated fat, which was partly attributed to regular red wine consumption.

Resveratrol also became one of the first compounds widely studied as a potential 'sirtuin activator' (STAC, sirtuin-activating compound) — targeting the enzyme SIRT1, which is linked to longevity mechanisms activated by caloric restriction in animal models. Despite decades of research and thousands of publications, the practical relevance of oral resveratrol supplementation in humans remains limited, mainly by the bioavailability problem.

Who can realistically expect to feel an effect? Small clinical studies have described a modest, inconsistent improvement in vascular endothelial function — this is the group closest to real beneficiaries: people who treat resveratrol as an additional element of a broader vascular health strategy, alongside diet and physical activity, rather than as a standalone solution. For people hoping for the effects reported in media coverage of in-vitro research — pronounced sirtuin activation, dramatic lifespan extension as seen in some animal models — oral supplementation will likely disappoint: pharmacokinetic data show that resveratrol is metabolized to inactive forms so quickly that the concentrations reached in tissue after a standard oral dose rarely come close to those tested on cell cultures. In other words, it's a low-risk supplement, but also one with limited, still weakly confirmed potential.

Where it's found

Resveratrol occurs naturally in the skin of red grapes (Vitis vinifera), in red wine, peanuts, berries, and in Japanese knotweed (Polygonum cuspidatum), native to East Asia and today the main industrial source of raw material for supplement production, cheaper than extraction from grape skin.

History of use

Interest in resveratrol exploded in the mid-2000s, when it became the scientific explanation offered for the so-called 'French paradox.' Subsequent studies in yeast, fruit flies and mice, suggesting lifespan extension driven by resveratrol as a purported 'sirtuin activator,' fueled a wave of commercial interest in the supplement around the turn of the 2010s, though later human clinical trials failed to confirm such dramatic effects — mainly because of the bioavailability problem.

Mechanism of action

Resveratrol may activate SIRT1 and pathways associated with so-called caloric restriction mimetics (which metabolically mimic the effects of reduced calorie intake without actual fasting), but its very low and variable bioavailability in humans — driven by rapid hepatic and intestinal metabolism (the first-pass effect) and a short half-life — significantly limits the translation of effective concentrations seen in vitro (in cell cultures) into the concentrations actually reached in tissue after oral supplementation.

The mechanism of SIRT1 activation by resveratrol itself remains a subject of scientific debate — some of the early work suggesting direct enzyme activation was later questioned as a possible methodological artifact of the fluorescence-based assays used to measure sirtuin activity. Independent of that debate, resveratrol shows the antioxidant activity typical of polyphenols — it neutralizes free radicals and may indirectly support the cell's own endogenous antioxidant systems, which is sometimes cited as an alternative or complementary explanation for the vascular and anti-inflammatory effects seen in studies, independent of the sirtuin pathway.

1

Absorption and rapid first-pass metabolism

After ingestion, resveratrol is quickly converted by the liver and intestines into inactive glucuronide and sulfate metabolites.

2

Potential SIRT1 activation

Some in-vitro studies point to resveratrol's ability to activate the sirtuin SIRT1, which is linked to longevity mechanisms under caloric restriction.

3

Antioxidant action of polyphenols

Independent of the sirtuin pathway, resveratrol neutralizes free radicals and may support vascular anti-inflammatory mechanisms.

4

Limited translation to target tissues

A short half-life and low systemic bioavailability mean that the concentrations reached in tissue after an oral dose are much lower than those used in cell-culture studies.

Evidence: early-stage — based on 2 studies in this database.

Benefits

In animals: improved metabolic parameters and lifespan extension in some models (mainly on a high-fat diet)
In humans: preliminary data on a beneficial effect on vascular endothelial function
Preliminary data on anti-inflammatory and antioxidant properties in small clinical studies
Theoretical support for metabolic health as a partial caloric-restriction mimetic

Common myths

MythA glass of red wine a day gives the same effect as a resveratrol supplement.

FactResveratrol doses used in clinical studies are on the order of hundreds of milligrams, while a glass of wine typically contains under 1 mg — and alcohol carries its own independent health risks.

MythSince resveratrol activates sirtuins in a test tube, it works just as powerfully in the human body.

FactVery low and variable bioavailability in humans (rapid hepatic metabolism) significantly limits the translation of striking in-vitro results into real tissue concentrations.

Forms & variants

Resveratrol comes in several forms that differ in bioavailability and use case — the form you pick genuinely matters for how effective the supplementation is.

Trans-resveratrol

The biologically active, more stable isomeric form — the one standardized in most clinically studied supplements.

Best for: The only form worth choosing — check the label for trans- content

Cis-resveratrol

A less stable isomer, formed partly under UV light, with significantly weaker biological activity than the trans form.

Best for: Undesirable in supplements — a sign of lower quality or product degradation

Micronized / liposomal resveratrol

Technologies aimed at improving resveratrol's poor bioavailability by shrinking particle size or encapsulating it in liposomes — preliminary data suggest some improvement in absorption, but human comparative studies remain limited.

Best for: An attempt to partly work around resveratrol's main limitation — low bioavailability

Japanese knotweed extract (Polygonum cuspidatum)

The most common industrial source of trans-resveratrol in supplements (cheaper than extraction from grape skin), with comparable purity when well manufactured.

Best for: The standard raw-material source in most available supplements

Practice

Frequently asked questions

No — resveratrol doses used in clinical studies are on the order of hundreds of milligrams, while a glass of red wine typically contains under 1 mg. Alcohol also carries its own health risks independent of resveratrol.

Resveratrol is very rapidly metabolized by the liver and intestines (the so-called first-pass effect) into inactive glucuronide and sulfate metabolites, before it can reach target tissues at a meaningful concentration — this is the main reason for the gap between spectacular in-vitro results and modest clinical effects in humans.

Dosage & timing

Typical dose

150–500 mg/day in clinical studies (the effective human dose is still not firmly established)

Form

Trans-resveratrol, ideally taken with fat or piperine to support absorption

Dosing is informational and reflects the ranges used in the cited studies — it does not replace consulting a doctor or pharmacist. Very low bioavailability means that in-vitro effects are hard to extrapolate directly to oral supplementation.

Best times to take it

  • With a meal containing fat, for better absorption

What to combine with

Good combinations

NMN (Nicotinamide Mononucleotide)A theoretical synergy in the context of the sirtuin/NAD+ pathway

Safety

Side effects & contraindications

Possible side effects

Gastrointestinal discomfort at high doses

Contraindications

Clotting disorders — potential antiplatelet effect

Hormone-dependent cancers — resveratrol shows weak estrogen-like activity

Interactions

Anticoagulants/antiplatelet drugs — theoretical risk of an enhanced effect

CYP3A4 substrates — possible effect on drug metabolism

Is it worth taking?

Who it's for

  • People interested in supporting vascular health as part of a broader longevity strategy
  • People aware of the bioavailability limitations, willing to treat it as a supporting supplement rather than a key one

Not for

  • Clotting disorders — potential antiplatelet effect
  • Hormone-dependent cancers — resveratrol shows weak estrogen-like activity

Evidence

Worth knowing

Only the trans-resveratrol form is biologically active — it's worth checking whether the manufacturer standardizes to this form.

Japanese knotweed (Polygonum cuspidatum) is the most common industrial source of resveratrol in supplements, cheaper than extraction from grape skin.

Taking it with a fat-containing meal supports somewhat better absorption.

Studies

Resveratrol supplementation is associated with a modest, inconsistent improvement in vascular endothelial function.

Fogacci F, et al., Nutrients, 2019

Resveratrol and cardiovascular health: a systematic review

Early-stage evidence

Fogacci F, et al. · Nutrients · 2019

A review pointing to a modest, inconsistent improvement in vascular endothelial function with resveratrol supplementation.

View study

Clinical pharmacokinetics of resveratrol and its metabolites

Strong evidence

Walle T. · Annals of the New York Academy of Sciences · 2011

A classic paper describing resveratrol's pharmacokinetics in humans and explaining the mechanism behind its very low systemic bioavailability.

View study

Sources & bibliography

Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.

Compare with similar entries

About the authors of this entry

AK

Author

dr Anna Kowalczyk

Editor-in-Chief, Molecular Biology

Anna oversees the editorial process and scientific review of every publication in the knowledge base. She previously researched autophagy and mitochondrial biology.

26 publications on this site

PZ

Medical review

dr Piotr Zieliński

Endocrinologist

Piotr reviews content on hormones, metabolic health and supplement pharmacology.

47 publications on this site

Published: 27 maja 2025Updated: 22 czerwca 2026

Related entries

Comments (2)

  • KW

    Kasia W. 2 weeks ago

    Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.

  • MT

    Marek T. a month ago

    Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.